The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125789372 12578937 2 F 20160707 20160721 20160721 EXP PHHY2016AU093602 SANDOZ 0.00 M Y 0.00000 20160721 MD AU AU

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125789372 12578937 1 PS CICLOSPORIN CYCLOSPORINE 1 Unknown U 65017
125789372 12578937 2 SS METHOTREXATE. METHOTREXATE 1 Unknown U 0
125789372 12578937 3 SS AZATHIOPRINE. AZATHIOPRINE 1 Unknown U 0
125789372 12578937 4 SS SECUKINUMAB SECUKINUMAB 1 Unknown 300 MG, UNK U 0 300 MG
125789372 12578937 5 SS MYCOPHENOLATE MYCOPHENOLIC ACID 1 Unknown U 0
125789372 12578937 6 SS CYCLOPHOSPHAMIDE. CYCLOPHOSPHAMIDE 1 Intravenous (not otherwise specified) U 0
125789372 12578937 7 SS ANAKINRA ANAKINRA 1 Unknown U 0 INJECTION
125789372 12578937 8 SS DAPSONE. DAPSONE 1 Unknown U 0
125789372 12578937 9 SS COLCHICINE. COLCHICINE 1 Unknown U 0
125789372 12578937 10 SS POTASSIUM IODIDE. POTASSIUM IODIDE 1 Unknown U 0
125789372 12578937 11 SS RITUXIMAB RITUXIMAB 1 Unknown 1 G, (2 DOSES) 0 1 G
125789372 12578937 12 SS PREDNISOLONE. PREDNISOLONE 1 Unknown 30 TO 50 MG DAILY U 0 50 MG
125789372 12578937 13 C INFLIXIMAB INFLIXIMAB 1 Unknown U 0
125789372 12578937 14 C TOCILIZUMAB TOCILIZUMAB 1 Unknown U 0
125789372 12578937 15 C WARFARIN WARFARIN 1 Unknown U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125789372 12578937 1 Neutrophilic dermatosis
125789372 12578937 2 Neutrophilic dermatosis
125789372 12578937 3 Neutrophilic dermatosis
125789372 12578937 4 Neutrophilic dermatosis
125789372 12578937 5 Neutrophilic dermatosis
125789372 12578937 6 Neutrophilic dermatosis
125789372 12578937 7 Neutrophilic dermatosis
125789372 12578937 8 Neutrophilic dermatosis
125789372 12578937 9 Neutrophilic dermatosis
125789372 12578937 10 Neutrophilic dermatosis
125789372 12578937 11 Neutrophilic dermatosis
125789372 12578937 12 Neutrophilic dermatosis
125789372 12578937 13 Neutrophilic dermatosis
125789372 12578937 14 Neutrophilic dermatosis
125789372 12578937 15 Deep vein thrombosis

Outcome of event

Event ID CASEID OUTC COD
125789372 12578937 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125789372 12578937 Bone marrow failure
125789372 12578937 Cataract
125789372 12578937 Drug ineffective
125789372 12578937 Glucose tolerance impaired
125789372 12578937 Injection site reaction
125789372 12578937 Ulcer
125789372 12578937 Weight increased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125789372 12578937 11 2015 0